Dr. Xianjin Dai is a Clinical Assistant Professor and American Board of Radiology certified Medical Physicist specializing in innovative biomedical imaging solutions for oncology applications. He holds his current position in the Department of Radiation Oncology at Stanford University where he leads translational research efforts in medical physics. Dr. Dai earned his PhD in Biomedical Engineering from the University of Florida and completed his CAMPEP-credited Therapeutic Medical Physics residency at Emory University before joining Stanford's faculty. His academic journey demonstrates a clear trajectory from foundational engineering education to clinical application development in radiation oncology physics.
Dr. Dai's research program focuses on developing and translating novel biomedical imaging techniques to enhance cancer diagnosis, management and treatment protocols. His work spans artificial intelligence in medicine, multimodal imaging integration, biomedical optics, photoacoustic imaging, ultrasound imaging and optical coherence tomography with particular emphasis on clinical applicability. His current projects include pioneering work on Large Language Model-Augmented Medical Image Analysis initiated in July 2022 and self-supervised learning approaches for accelerated 3D high-resolution ultrasound imaging. With over 1,250 citations according to Google Scholar, his contributions have established him as an emerging authority in medical imaging physics with significant impact in both engineering and clinical domains.
His scientific leadership extends beyond laboratory research through prestigious recognitions including the DOD Prostate Cancer Research Program Early Investigator Research Award and the American Association of Physicists in Medicine Research Seed Funding Grant. Since 2023, Dr. Dai has served as Associate Editor for Medical Physics Journal, demonstrating growing influence in his field. His work continues to bridge engineering innovation with clinical oncology needs through ongoing investigations into multimodal imaging approaches. Dr. Dai remains committed to advancing precision medicine through novel imaging technologies that directly benefit cancer patient care and treatment outcomes.
